Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
30 participants
INTERVENTIONAL
2019-06-29
2019-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Ultrasound Cavitation Focused on Located Adiposity
NCT02539043
Effects of Capacitive Radiofrequency at the Dermis and Adipose Tissue
NCT04182542
Effect of Shock Wave Therapy Without Biological and Immuno-histochemical Analysis.
NCT05017636
Low-Frequency, High-Intensity Ultrasound for Waist Circumference Reduction
NCT04206384
Effects of Radiofrequency on Located Adiposity
NCT02546778
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group control
You will not receive any type of intervention
No interventions assigned to this group
treatment group (ultrasound)
Will perform protocols of 10 sessions of ultrasound in the region of abdomen
ultrassound
The treatment protocol will consist of 10 sessions, lasting 20 minutes. The energy level corresponding to 59 J / cm2 (177 J / cm2) and frequency of 3 MHZ, applied in the anterior region of the abdomen, in a quadrant previously delimited with a ballpoint pen, will be used. The flanks (lateral of the abdomen) will not be treated.
placebo group
It will perform protocols of 10 sessions of ultrasound in the region of abdomen, but the apparatus will be with zero intensities
ultrassound
The treatment protocol will consist of 10 sessions, lasting 20 minutes. The energy level corresponding to 59 J / cm2 (177 J / cm2) and frequency of 3 MHZ, applied in the anterior region of the abdomen, in a quadrant previously delimited with a ballpoint pen, will be used. The flanks (lateral of the abdomen) will not be treated.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrassound
The treatment protocol will consist of 10 sessions, lasting 20 minutes. The energy level corresponding to 59 J / cm2 (177 J / cm2) and frequency of 3 MHZ, applied in the anterior region of the abdomen, in a quadrant previously delimited with a ballpoint pen, will be used. The flanks (lateral of the abdomen) will not be treated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Preserved elasticity and local tissue integrity;
* In addition, participants had to agree not to change their daily routines during the study.
Exclusion Criteria
* Breastfeeding;
* History of liposuction;
* Lipolysis by injection therapy;
* Abdominoplasty or surgery in the treatment region;
* Weight reduction medication;
* Recent surgery in the last 12 months;
* Implantable electrical device;
* Neurosurgical deviation;
* Hernia;
* Sensory loss or dysesthesia in the treatment region;
* Cancer;
* Circulation problems;
* Or chronic systemic disease such as diabetes or metabolic syndrome.
18 Years
30 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
São Paulo State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Jaqueline Lopes
Barra do Garças, Mount, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SaoPSU_univar
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.